BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 33584719)

  • 1. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
    Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
    Front Immunol; 2020; 11():621441. PubMed ID: 33584719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19.
    Liu S; Wang B; Chen T; Wang H; Liu J; Zhao X; Zhang Y
    Front Immunol; 2024; 15():1374541. PubMed ID: 38807598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
    Wang YC; Tsai CH; Wang YC; Yen LC; Chang YW; Sun JR; Lin TY; Chiu CH; Chao YC; Chang FY
    Infection; 2024 Jun; 52(3):955-983. PubMed ID: 38133713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota.
    Liu T; Wu J; Han C; Gong Z; Regina G; Chen J; Dou F; Silvestri R; Chen C; Yu Z
    Int J Biol Sci; 2021; 17(13):3305-3319. PubMed ID: 34512148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
    Patra T; Meyer K; Geerling L; Isbell TS; Hoft DF; Brien J; Pinto AK; Ray RB; Ray R
    PLoS Pathog; 2020 Dec; 16(12):e1009128. PubMed ID: 33284859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
    Nasonov E; Samsonov M
    Biomed Pharmacother; 2020 Nov; 131():110698. PubMed ID: 32920514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.
    Chukwuma IF; Apeh VO; Chiletugo OF
    Acta Virol; 2021; 65(1):3-9. PubMed ID: 33112637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.